FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Nagesh Sukhi

2. Date of Event Requiring Statement (MM/DD/YYYY)
5/22/2015 

3. Issuer Name and Ticker or Trading Symbol

MARVELL TECHNOLOGY GROUP LTD [MRVL]

(Last)        (First)        (Middle)

5488 MARVELL LANE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
interim CFO /

(Street)

SANTA CLARA, CA 95054       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Shares   5713   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)     (1) 6/27/2021   Common Shares   6250   $14.14   D    
Restricted Stock Units (Right to Acquire)     (2)   (2) Common Shares   2000     (3) D    
Employee Stock Option (Right to Buy)     (4) 4/21/2022   Common Shares   6124   $15.20   D    
Employee Stock Option (Right to Buy)     (5) 4/30/2023   Common Shares   24750   $10.76   D    
Restricted Stock Units (Right to Acquire)     (6)   (6) Common Shares   325     (3) D    
Employee Stock Option (Right to Buy)     (7) 3/3/2024   Common Shares   7500   $15.43   D    
Restricted Stock Units (Right to Acquire)     (8)   (8) Common Shares   7500     (3) D    
Employee Stock Option (Right to Buy)     (9) 6/16/2024   Common Shares   40000   $14.59   D    
Restricted Stock Units (Right to Acquire)     (10)   (10) Common Shares   8800     (3) D    

Explanation of Responses:
( 1)  Original option amount of 25,000 options vest and become exercisable at the rate of 1/5th of the shares on May 09, 2012 and 1/60th of the shares after the completion of each additional month of employment with Marvell Technology Group Ltd. ("Marvell") therafter over the next four years.
( 2)  The reporting person received 10,000 restricted stock units subject to a five-year vesting schedule, vesting 1/5th on May 15, 2012 and 1/20th after each full three (3) months of employment with Marvell thereafter over the next four years; provided employment is served through each applicable vesting date. Upon vesting, Marvell common shares will be delivered to the reporting person.
( 3)  Each restricted stock unit represents a contingent right to receive one Marvell common share.
( 4)  Original option amount of 12,250 options vest and become exercisable in four equal annual installments beginning on April 1, 2013 and every year thereafter; provided employment is served through each applicable vesting date.
( 5)  Original option amount of 24,750 options vest and become exercisable in three equal annual installments beginning on April 1, 2015 and each year thereafter; provided employment is served through each applicable vesting date.
( 6)  The reporting person received 1,300 restricted stock units subject to a four-year vesting schedule, vesting at 25% on April 1, 2013 and 25% each year thereafter; provided employment is served through each applicable vesting date. Upon vesting, Marvell common shares will be delivered to the reporting person.
( 7)  Original option amount of 10,000 options vest and become exercisable in four equal annual installments beginning on January 27, 2015 and every year thereafter; provided employment is served through each applicable vesting date.
( 8)  The reporting person received 10,000 restricted stock units subject to a four-year vesting schedule, vesting at 25% on February 15, 2015 and 25% each year thereafter; provided employment is served through each applicable vesting date. Upon vesting, Marvell common shares will be delivered to the reporting person.
( 9)  Option amount of 40,000 options vest and become exercisable in two equal annual installments beginning on April 1, 2017 and the following year; provided employment is served through each applicable vesting date.
( 10)  The original performance-based grant was for 20,000 restricted stock units subject to the achievement of certain performance criteria. A portion of the criteria was determined to be met and 8,800 shares will vest on April 1, 2016; provided employment is served through the vesting date. Upon vesting, Marvell common shares will be delivered to the reporting person.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Nagesh Sukhi
5488 MARVELL LANE
SANTA CLARA, CA 95054


interim CFO

Signatures
/s/ Sukhi Nagesh 6/1/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Marvell Technology (NASDAQ:MRVL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Marvell Technology Charts.
Marvell Technology (NASDAQ:MRVL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Marvell Technology Charts.